Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Talactoferrinum alfa

EU orphan designation number: EU/3/07/448   
Active ingredient: Talactoferrinum alfa
Indication: Treatment of renal cell carcinoma
Sponsor: Agennix Limited
Carmelite, 50 Victoria Embankment, Blackfriars, London, EC4Y 0DX, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
07/06/2007 Centralised Orphan - Designation EMEA/OD/010/07 (2007)2485 of 05/06/2007